| [1] | Isacsson G, Holmgren P, Druid H, Bergman U (1999) Psychotropics and suicide prevention. Implications from toxicological screening of 5281 suicides in Sweden 1992–1994. Br J Psychiatry 174: 259–265.
|
| [2] | Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, et al. (1996) Cross-national epidemiology of major depression and bipolar disorder. JAMA 276: 293–299.
|
| [3] | Wong ML, Licinio J (2005) Biology of depression: From novel insights to therapeutic strategies. Weinheim (Germany): Wiley-VCH. 1092 p.
|
| [4] | Wong ML, Licinio J (2004) From monoamines to genomic targets: A paradigm shift for drug discovery in depression. Nat Rev Drug Discov 3: 136–151.
|
| [5] | Wong ML, Licinio J (2001) Research and treatment approaches to depression. Nature Rev Neurosci 2: 343–351.
|
| [6] | Wu LT, Anthony JC (2000) The estimated rate of depressed mood in US adults: Recent evidence for a peak in later life. J Affect Disord 60: 159–171.
|
| [7] | Roberts RE, Kaplan GA, Shema SJ, Strawbridge WJ (1997) Does growing old increase the risk for depression? Am J Psychiatry 154: 1384–1390.
|
| [8] | Roberts RE, Kaplan GA, Shema SJ, Strawbridge WJ (1997) Prevalence and correlates of depression in an aging cohort: The Alameda County Study. J Gerontol B Psychol Sci Soc Sci 52: S252–S258.
|
| [9] | Kochanek KD, Smith BL (2004) Deaths: Preliminary data for 2002. Natl Vial Stat Rep 52: 1–47.
|
| [10] | Moller HJ (2003) Suicide, suicidality and suicide prevention in affective disorders. Acta Psychiatr Scand Suppl 73–80.
|
| [11] | Goodwin FK, Jamison KR (1990) Manic-depressive illness. New York: University Press. 938 p.
|
| [12] | Guze SB, Robins E (1970) Suicide and primary affective disorders. Br J Psychiatry 117: 437–438.
|
| [13] | Inskip HM, Harris EC, Barraclough B (1998) Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. Br J Psychiatry 172: 35–37.
|
| [14] | Blair-West GW, Mellsop GW, Eyeson-Annan ML (1997) Down-rating lifetime suicide risk in major depression. Acta Psychiatr Scand 95: 259–263.
|
| [15] | Blair-West GW, Cantor CH, Mellsop GW, Eyeson-Annan ML (1999) Lifetime suicide risk in major depression: Sex and age determinants. J Affect Disord 55: 171–178.
|
| [16] | Boardman AP, Healy D (2001) Modelling suicide risk in affective disorders. Eur Psychiatry 16: 400–405.
|
| [17] | Bostwick JM, Pankratz VS (2000) Affective disorders and suicide risk: A reexamination. Am J Psychiatry 157: 1925–1932.
|
| [18] | Henriksson MM, Aro HM, Marttunen MJ, Heikkinen ME, Isometsa ET, et al. (1993) Mental disorders and comorbidity in suicide. Am J Psychiatry 150: 935–940.
|
| [19] | Balazs J, Lecrubier Y, Csiszer N, Kosztak J, Bitter L (2003) Prevalence and comorbidity of affective disorders in persons making suicide attempts in Hungary: Importance of the first depressive episodes and of bipolar II diagnoses. J Affect Disord 76: 113–119.
|
| [20] | Shafii M, Steltz-Lenarsky J, Derrick AM, Beckner C, Whittinghill JR (1988) Comorbidity of mental disorders in the post-mortem diagnosis of completed suicide in children and adolescents. J Affect Disord 15: 227–233.
|
| [21] | Shaffer D, Gould MS, Fisher P, Trautman P, Moreau D, et al. (1996) Psychiatric diagnosis in child and adolescent suicide. Arch Gen Psychiatry 53: 339–348.
|
| [22] | Wong DT, Bymaster FP, Engleman EA (1995) Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publication. Life Sci 57: 411–441.
|
| [23] | Guze BH, Gitlin M (1994) New antidepressants and the treatment of depression. J Fam Pract 38: 49–57.
|
| [24] | American Medical Association (1992) Psychopharmacologic drugs. In: Drugs used in mood disorders. Drug Evaluation Subscription 1: 32.
|
| [25] | Rossi A, Barraco A, Donda P (2004) Fluoxetine: A review on evidence based medicine. Ann Gen Hosp Psychiatry 3: 2.
|
| [26] | Stokes PE, Holtz A (1997) Fluoxetine tenth anniversary update: The progress continues. Clin Ther 19: 1135–1250.
|
| [27] | US Census Bureau (2002) Demographic Trends in the 20th Century (Census 2000 Special Reports). Available: http://www.census.gov/prod/2002pubs/cens？r-4.pdf. Accessed 9 May 2006 .
|
| [28] | US Census Bureau (2005) Population estimates. Available: http://www.census.gov/popest/estimates.p？hp.Accessed 9 May 2006.
|
| [29] | US Census Bureau (2005) US Census Bureau (2005) American FactFinder: Population Estimates Program. Available: http://www.factfinder.census.gov/home/sa？ff/main.html?_lang=en. Accessed 9 May 2006 .
|
| [30] | National Center for Health Statistics (1998) Technical appendix. Vital statistics of the United States, 1994, volume II, mortality, part A. Washington (D. C.): Public Health Service. Available: http://www.cdc.gov/nchsw. Accessed 1 September 2005 .
|
| [31] | Anderson RN, Rosenberg HM (1998) Age standardization of death rates: Implementation of the Year 2000 Standard. Natl Vital Stat Rep 47: 1–16.
|
| [32] | Day JC, U.S. Bureau of the Census (1996) Population projections of the United States by age, sex, race, and Hispanic origin: 1995 to 2050. Current population reports; series P-25, number 1130. Washington (D. C.): U.S. Government Printing Office.
|
| [33] | Zellner A (1996) An introduction to Bayesian inference in econometrics. New York: Wiley.
|
| [34] | Bayes CS (1993) Regression with autoregressive errors: A Gibbs sampling approach. J Econom 58: 275–294.
|
| [35] | Broemeling LD, Cook P (1993) Bayesian estimation of the means of the AR process. J Appl Stat 20: 25–39.
|
| [36] | Zellner A, Tiao G (1964) Bayesian analysis of the regression model with autocorrelated errors. J Am Stat Assoc 59: 763–778.
|
| [37] | Sleath B, Shih YC (2003) Sociological influences on antidepressant prescribing. Soc Sci Med 56: 1335–1344.
|
| [38] | Grunebaum MF, Ellis SP, Li S, Oquendo MA, Mann JJ (2004) Antidepressants and suicide risk in the United States, 1985–1999. J Clin Psychiatry 65: 1456–1462.
|
| [39] | Hall WD, Mant A, Mitchell PB, Rendle VA, Hickie IB, McManus P (2003) Association between antidepressant prescribing and suicide in Australia, 1991–2000: Trend analysis. BMJ 326: 1008.
|
| [40] | Isacsson G (2000) Suicide prevention—A medical breakthrough? Acta Psychiatr Scand 102: 113–117.
|
| [41] | Carlsten A, Waern M, Ekedahl A, Ranstam J (2001) Antidepressant medication and suicide in Sweden. Pharmacoepidemiol Drug Saf 10: 525–530.
|
| [42] | Rihmer Z (2001) Can better recognition and treatment of depression reduce suicide rates? A brief review. Eur Psychiatry 16: 406–409.
|
| [43] | Fergusson D, Doucette S, Glass KC, Shapiro S, Healy D, Hebert P, Hutton B (2005) Association between suicide attempts and selective serotonin reuptake inhibitors: Systematic review of randomised controlled trials. BMJ 330: 396–399.
|
| [44] | Martinez C, Rietbrock S, Wise L, Ashby D, Chick J, Moseley J, Evans S, Gunnell D (2005) Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: Nested case-control study. BMJ 330: 389–393.
|
| [45] | Gunnell D, Saperia J, Ashby D (2005) Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: Meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ 330: 385–388.
|
| [46] | Gunnell D, Ashby D (2004) Antidepressants and suicide: What is the balance of benefit and harm. BMJ 329: 34–38.
|
| [47] | Gibbons RD, Hur K, Bhaumik DK, Mann JJ (2005) The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry 62: 165–172.
|
| [48] | Weller EB, Tucker S, Weller RA (2005) The selective serotonin reuptake inhibitors controversy in the treatment of depression in children. Curr Psychiatry Rep 7: 87–90.
|
